On the methanolysis of KBBL, an immunostimulant derived from ascorbic acid

Methanolysis of the immunostimulant KBBL ( 1a) was studied to provide new internal ketal derivatives for potential elaboration of the butyrolactone nucleus (derived from ascorbic acid). Treatment of the immunostimulant KBBL ( 1a) in dry methanol with Amberlyst® 15 as catalyst yielded the epimeric sp...

Full description

Saved in:
Bibliographic Details
Published inTetrahedron Vol. 49; no. 34; pp. 7437 - 7444
Main Authors Campbell, Erin, Newhouse, Bradley J, Bordner, Jon, Kleinman, Edward F
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 20.08.1993
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methanolysis of the immunostimulant KBBL ( 1a) was studied to provide new internal ketal derivatives for potential elaboration of the butyrolactone nucleus (derived from ascorbic acid). Treatment of the immunostimulant KBBL ( 1a) in dry methanol with Amberlyst® 15 as catalyst yielded the epimeric spiro ketals 4a and 4b along with a minor amount of the pyranoid ketal 2. Contrary to a literature report, treatment of KBBL in 2% methanolic HCl gave the rearranged methyl ester 3 rather than ketal 2. Ketals 2, 4a, and 4b are potentially useful intermediates for the further elaboration of the ascorbic acid nucleus of KBBL because the ketone and one hydroxyl of the butyrolactone nucleus (derived from ascorbic acid) are simultaneously protected as an internal ketal. X-Ray structures of these compounds were obtained, contributing to our knowledge of the structure of the KBBL family of immunostimulants.
ISSN:0040-4020
1464-5416
DOI:10.1016/S0040-4020(01)87220-3